UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Science (American Association for the Advancement of Science), 2011-03, Vol.331 (6024), p.1565-1570

2011

Volltextzugriff (PDF)

Tumor-infiltrating NY-ESO-1-specific CD8⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (17), p.7875-7880

2010

Volltextzugriff (PDF)

Adaptive immunity maintains occult cancer in an equilibrium state

Nature, 2007-12, Vol.450 (7171), p.903-907

2007

Volltextzugriff (PDF)

The Immunobiology of Cancer Immunosurveillance and Immunoediting

Immunity, 2004-08, Vol.21 (2), p.137-148

2004

Volltextzugriff (PDF)

Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients

Clinical cancer research, 2012-12, Vol.18 (23), p.6497-6508

2012

Volltextzugriff (PDF)

The three Es of cancer immunoediting

Annual review of immunology, 2004-01, Vol.22 (1), p.329-360

2004

Volltextzugriff (PDF)

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (40), p.16723-16728

2011

Volltextzugriff (PDF)

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

Proceedings of the National Academy of Sciences - PNAS, 2012-04, Vol.109 (15), p.5797-5802

2012

Volltextzugriff (PDF)

PEGylated Gold Nanoparticles Conjugated to Monoclonal F19 Antibodies as Targeted Labeling Agents for Human Pancreatic Carcinoma Tissue

ACS nano, 2008-11, Vol.2 (11), p.2263-2272

2008

Volltextzugriff (PDF)

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Proceedings of the National Academy of Sciences - PNAS, 2007-03, Vol.104 (10), p.3967-3972

2007

Volltextzugriff (PDF)

Genome-wide analysis of cancer/testis gene expression

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (51), p.20422-20427

2008

Volltextzugriff (PDF)

Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes and a High $CD8^+/regulatory$ T Cell Ratio Are Associated with Favorable Prognosis in Ovarian Cancer

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (51), p.18538-18543

2005

Volltextzugriff (PDF)

CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

Clinical cancer research, 2007-12, Vol.13 (23), p.6947-6958

2007

Volltextzugriff (PDF)

Cancer immunoediting: from immunosurveillance to tumor escape

Nature immunology, 2002-11, Vol.3 (11), p.991-998

2002

Volltextzugriff (PDF)

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (51), p.20410-20415

2008

Volltextzugriff (PDF)

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Immunological reviews, 2002-10, Vol.188 (1), p.22-32

2002

Volltextzugriff (PDF)

Antibody therapy of cancer

Nature reviews. Cancer, 2012-04, Vol.12 (4), p.278-287

2012

Volltextzugriff (PDF)

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals

Clinical cancer research, 2010-05, Vol.16 (10), p.2781-2791

2010

Volltextzugriff (PDF)

Seromic profiling of ovarian and pancreatic cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-03, Vol.107 (11), p.5088-5093

2010

Volltextzugriff (PDF)

Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

Clinical cancer research, 2005-11, Vol.11 (22), p.8055-8062

2005

Volltextzugriff (PDF)

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (31), p.12837-12842

2007

Volltextzugriff (PDF)

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124 I-cG250) and PET in patients with renal masses: a phase I trial

The lancet oncology, 2007-04, Vol.8 (4), p.304-310

2007

Volltextzugriff (PDF)

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (21), p.8947-8952

2007

Volltextzugriff (PDF)

MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer

PloS one, 2011-07, Vol.6 (7), p.e21366-e21366

2011

Volltextzugriff (PDF)

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers

PloS one, 2011-03, Vol.6 (3), p.e17876-e17876

2011

Volltextzugriff (PDF)

1 – 25 von 770

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(694)
Mit Volltextzugriff
(711)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(510)
Humans
(464)
Life Sciences & Biomedicine
(369)
Animals
(270)
Biological And Medical Sciences
(243)
Mice
(229)
Female
(208)
Tumors
(199)
Medical Sciences
(186)
Oncology
(175)
Antigens, Neoplasm - Immunology
(164)
Male
(164)
Antigens
(138)
Science & Technology - Other Topics
(135)
Multidisciplinary Sciences
(134)
Immunology
(132)
Antigens, Neoplasm - Genetics
(95)
Middle Aged
(88)
Melanoma - Immunology
(87)
Cancer
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Tumor-infiltrating NY-ESO-1-specific CD8⁺ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Adaptive immunity maintains occult cancer in an equilibrium state

The Immunobiology of Cancer Immunosurveillance and Immunoediting

Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients

The three Es of cancer immunoediting

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

PEGylated Gold Nanoparticles Conjugated to Monoclonal F19 Antibodies as Targeted Labeling Agents for Human Pancreatic Carcinoma Tissue

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Genome-wide analysis of cancer/testis gene expression

Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes and a High $CD8^+/regulatory$ T Cell Ratio Are Associated with Favorable Prognosis in Ovarian Cancer

CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

Cancer immunoediting: from immunosurveillance to tumor escape

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Antibody therapy of cancer

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals

Seromic profiling of ovarian and pancreatic cancer

Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124 I-cG250) and PET in patients with renal masses: a phase I trial

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers

Suchergebnisse filtern